Literature DB >> 10080139

Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis.

T Rokkas1, S Ladas, C Liatsos, E Petridou, G Papatheodorou, S Theocharis, A Karameris, S Raptis.   

Abstract

Despite the fact that the association of Helicobacter pylori with an increased risk of gastric cancer is well documented, the exact mechanisms of this association have not been elucidated. Our aim was to shed some light on these mechanisms by studying the relationship of H. pylori CagA status to gastric cell proliferation and apoptosis, since both play an important role in gastrointestinal epithelial cell turnover and carcinogenesis. We studied fifty patients [32 men, 18 women, median age 39.5 years (range 18-67)], referred for upper gastrointestinal endoscopy, from whom antral biopsies were taken. On biopsy specimens gastritis was estimated by scoring the severity of inflammatory infiltrate, and the presence of atrophy and intestinal metaplasia were also noted. The gastric cell proliferation index (PI) was estimated by AgNOR staining, the epithelial apoptotic index (AI) was measured by special staining for apoptosis, and CagA status was determined serologically by immunoblotting the sera of patients against H. pylori antigens. Thirty-eight (76%) of the 50 patients were H. pylori (positive) and 12 (24%) H. pylori (negative). Among the 38 H. pylori(+) patients, 28 (73.6%) were CagA(+) and 10 (24.6%) CagA(-). In the H. pylori CagA(+) and CagA(-) groups, the PI values [median (ranges)] were 5 (4-7) and 3.7 (3.5-5.5), respectively (P < 0.05). In addition the difference in PI between the H. pylori CagA(+) and H. pylori(-) groups was highly significant (P < 0.001). Concerning apoptosis, in the H. pylori CagA(+) and CagA(-) groups, the values for AI were 1 (1-30) and 5.5 (1-35), respectively (P < 0.05). In addition, the difference in AI between the H. pylori CagA(-) and H. pylori(-) groups, was significant (P < 0.05). We conclude that H. pylori CagA(+) strains induce increased gastric cell proliferation, which is not accompanied by a parallel increase in apoptosis. This might explain the increased risk for gastric carcinoma that is associated with infection by H. pylori CagA(+) strains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10080139     DOI: 10.1023/a:1026636803101

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  46 in total

1.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

2.  Rapid staining of Campylobacter pyloridis.

Authors:  H V Potters; R J Loffeld; E Stobberingh; J P van Spreeuwel; J W Arends
Journal:  Histopathology       Date:  1987-11       Impact factor: 5.087

3.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

Review 4.  Gastric epithelial cell proliferation.

Authors:  R J Cahill; C A O'Morain
Journal:  Eur J Cancer Prev       Date:  1994-12       Impact factor: 2.497

5.  Helicobacter pylori and atrophic gastritis: importance of the cagA status.

Authors:  E J Kuipers; G I Pérez-Pérez; S G Meuwissen; M J Blaser
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

6.  Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma.

Authors:  L E Hansson; L Engstrand; O Nyrén; D J Evans; A Lindgren; R Bergström; B Andersson; L Athlin; O Bendtsen; P Tracz
Journal:  Gastroenterology       Date:  1993-10       Impact factor: 22.682

7.  Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.

Authors:  B J Marshall; J R Warren; G J Francis; S R Langton; C S Goodwin; E D Blincow
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

8.  Gastric adenocarcinoma and Helicobacter pylori infection.

Authors:  N J Talley; A R Zinsmeister; A Weaver; E P DiMagno; H A Carpenter; G I Perez-Perez; M J Blaser
Journal:  J Natl Cancer Inst       Date:  1991-12-04       Impact factor: 13.506

9.  Inhibition of apoptosis during development of colorectal cancer.

Authors:  A Bedi; P J Pasricha; A J Akhtar; J P Barber; G C Bedi; F M Giardiello; B A Zehnbauer; S R Hamilton; R J Jones
Journal:  Cancer Res       Date:  1995-05-01       Impact factor: 12.701

10.  Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer.

Authors:  J E Crabtree; J I Wyatt; G M Sobala; G Miller; D S Tompkins; J N Primrose; A G Morgan
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

View more
  28 in total

1.  Epithelial intestinal cell apoptosis induced by Helicobacter pylori depends on expression of the cag pathogenicity island phenotype.

Authors:  G Le'Negrate; V Ricci; V Hofman; B Mograbi; P Hofman; B Rossi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Gastric mucosa epithelial cell kinetics are differentiated by anatomic site and Helicobacter pylori infection.

Authors:  Panagiota Kitsanta; Konstantinos Triantafyllou; Maria Chatziargyriou; Charalambos Barbatzas; Spiros D Ladas
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

3.  Incomplete intestinal metaplasia as an indicator for early detection of gastric carcinoma in the events of helicobacter pylori positive chronic atrophic gastritis.

Authors:  Zora Vukobrat-Bijedić; Svjetlana Radović; Azra Husić-Selimović; Srdan Gornjaković
Journal:  Bosn J Basic Med Sci       Date:  2006-11       Impact factor: 3.363

4.  Distinct diversity of vacA, cagA, and cagE genes of Helicobacter pylori associated with peptic ulcer in Japan.

Authors:  Shiho Yamazaki; Akiyo Yamakawa; Tomoyuki Okuda; Masahiro Ohtani; Hiroyuki Suto; Yoshiyuki Ito; Yukinao Yamazaki; Yoshihide Keida; Hideaki Higashi; Masanori Hatakeyama; Takeshi Azuma
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions.

Authors:  J Yu; W K Leung; M Y Y Go; M C W Chan; K F To; E K W Ng; F K L Chan; T K W Ling; S C S Chung; J J Y Sung
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

6.  Effect of Helicobacter pylori infection on epidermal growth factor receptor (EGFR) expression and cell proliferation of gastric epithelial mucosa: correlation to macroscopic and microscopic diagnosis.

Authors:  Agnes Ruzsovics; Zsuzsa Unger; Bela Molnar; Laszlo Pronai; Zsolt Tulassay
Journal:  Int J Exp Pathol       Date:  2002-10       Impact factor: 1.925

7.  The association between cagA+ H. pylori infection and distal gastric cancer: a proposed model.

Authors:  Mohammed S Al-Marhoon; Sheila Nunn; Roger W Soames
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

8.  Helicobacter pylori-specific immune responses of children: implications for future vaccination strategy.

Authors:  Günter Bode; Isolde Piechotowski; Dietrich Rothenbacher; Hermann Brenner
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

9.  Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease.

Authors:  Nawfal R Hussein; Marjan Mohammadi; Yeganeh Talebkhan; Masoumeh Doraghi; Darren P Letley; Merdan K Muhammad; Richard H Argent; John C Atherton
Journal:  J Clin Microbiol       Date:  2008-03-19       Impact factor: 5.948

10.  CagA and VacA Helicobacter pylori antibodies in gastric cancer.

Authors:  R Suriani; M Colozza; E Cardesi; D Mazzucco; M Marino; S Grosso; S Sanseverinati; I Venturini; A Borghi; M Luisa Zeneroli
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.